|Gefen Biomed Investments Ltd -- Israel Stock|| |
ILS 4.8 0.00 0.00%
CEO of the Company and of some of its Subsidiaries
Ms. Limor Kohen was appointed Director at Gefen Biomed Investments Ltd, in addition to her roles of Chief Executive Officer of the Company and of some of its Subsidiaries, effective August 29, 2017. Her work experience includes the following roles Chief Executive Officer at the Company, Director at the Company, Chief Executive Officer of some Subsidiaries of the Company, Deputy Chief Executive Officer at the Company, Vice PresidentSales at Eurocom and Managing Director at Treatec 21 Industries Ltd . She holds a Bachelor of Business Administration degree, majoring in Finance and Marketing, from Hamichlala Leminhal.
Age: 52 CEO Since 2017
972 8 675 1122 http://www.gefenbiomed.com
The company has return on total asset (ROA)
of 20.33 %
which means that it generated profit of $20.33 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 20.23 M in total debt with debt to equity ratio (D/E) of 0.49 which is about average as compared to similar companies. Gefen Biomed Investments Ltd has Current Ratio of 0.58 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Gefen Biomed Investments Ltd engages in the location, screening, and investment in earlystage medical devices and biotechnology companies. Gefen Biomed Investments Ltd (GEFEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Ashkelon, and employs 12 people.